RNS Number : 7372G
Smiths Group PLC
25 July 2019
25 July 2019
SMITHS GROUP PLC ("Smiths")
As part of the Board's normal succession planning the Board is pleased to announce the appointment of Pam Cheng as an independent non-executive Director. The appointment will take effect from 1 March 2020. On joining the Board Pam will become a member of the Nomination & Governance, Audit & Risk and Remuneration Committees. Biographic details are set out below.
Smiths Chairman Sir George Buckley said:
"I am delighted that Pam has agreed to join the Smiths Board.
Pam's experience in the areas of manufacturing, supply chain and technology gained with large global businesses in strategically important regions for Smiths will further strengthen the Board's discussions on embedding world class operations."
Pam Cheng, Executive Vice-President, Operations and Information Technology, joined AstraZeneca in June 2015 after having spent 18 years in Global Manufacturing, Supply Chain and Commercial roles at Merck/MSD. Pam Cheng was President of MSD China, responsible for MSD's entire business in China prior to joining AstraZeneca. She was the Head of Global Supply Chain Management & Logistics for Merck from 2006 to 2011 and led the transformation of Merck supply chains across the global supply network. Prior to joining Merck, she held various engineering and project management positions at Universal Oil Products, Union Carbide Corporation and GAF Chemicals. Pam is also an independent non-executive Director of the US listed company Codexis Inc. Pam holds Bachelor's and Master's degrees in chemical engineering from Stevens Institute of Technology in New Jersey and an MBA in marketing from Pace University in New York.
There is no further information required to be disclosed pursuant to LR 9.6.13.
Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11
About Smiths Group
Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). Its businesses share common characteristics (well-positioned in growing markets, technology-led, asset-light, digitising, with a high proportion of aftermarket revenues) and a common operating model (The Smiths Excellence System). For more information visit www.smiths.com.
This information is provided by RNS, the news service of the London Stock Exchange
. RNS is approved by the Financial Conduct Authority
to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org
or visit www.rns.com